Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,250,726 papers from all fields of science
Search
Sign In
Create Free Account
piperidine-4-sulfonic acid
Known as:
4-Piperidinesulfonic acid
, piperidine-4-sulphonic acid
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
GABA Agonists
Piperidines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2006
Highly Cited
2006
Pharmacological Characterization of Agonists at δ-Containing GABAA Receptors: Functional Selectivity for Extrasynaptic Receptors Is Dependent on the Absence of γ2
Signe í Stórustovu
,
B. Ebert
Journal of Pharmacology and Experimental…
2006
Corpus ID: 13617708
Several groups have characterized the pharmacology of α4- or α6β3δ-containing GABAA receptors expressed in different cell systems…
Expand
Highly Cited
2004
Highly Cited
2004
Activation of single heteromeric GABAA receptor ion channels by full and partial agonists
M. Mortensen
,
U. Kristiansen
,
B. Ebert
,
B. Frølund
,
P. Krogsgaard‐Larsen
,
T. Smart
Journal of Physiology
2004
Corpus ID: 33891107
The linkage between agonist binding and the activation of a GABAA receptor ion channel is yet to be resolved. This aspect was…
Expand
2000
2000
Allosteric modulators affect the efficacy of partial agonists for recombinant GABAA receptors
G. Maksay
,
S. Thompson
,
K. Wafford
British Journal of Pharmacology
2000
Corpus ID: 29994610
Different α subunits of human γ‐aminobutyric acid type A (GABAA) receptors were transiently expressed together with β3 and γ2…
Expand
Highly Cited
1999
Highly Cited
1999
Mutation at the putative GABAA ion‐channel gate reveals changes in allosteric modulation
S. Thompson
,
Maria Z Smith
,
P. Wingrove
,
P. Whiting
,
K. Wafford
British Journal of Pharmacology
1999
Corpus ID: 1361115
We have mutated a conserved leucine in the putative membrane‐spanning domain to serine in human GABAA β2 and investigated the…
Expand
Highly Cited
1996
Highly Cited
1996
Functional characterization of human gamma-aminobutyric acidA receptors containing the alpha 4 subunit.
K. Wafford
,
S. Thompson
,
D. Thomas
,
James M. Sikela
,
A. Wilcox
,
Paul J. Whiting
Molecular Pharmacology
1996
Corpus ID: 41660601
The alpha subunits are an important determinant of the pharmacology of gamma-aminobutyric acidA (GABAA) receptors with respect to…
Expand
Highly Cited
1990
Highly Cited
1990
Characterization of gabaergic seizure regulation in the midline thalamus
John W. Miller
,
J. Ferrendelli
Neuropharmacology
1990
Corpus ID: 41584721
Highly Cited
1990
Highly Cited
1990
The central medial nucleus: thalamic site of seizure regulation
John W. Miller
,
J. Ferrendelli
Brain Research
1990
Corpus ID: 35823040
1985
1985
GABA‐Mimetic Activity and Effects on Diazepam Binding of Aminosulphonic Acids Structurally Related to Piperidine‐4‐Sulphonic Acid
E. Falch
,
P. Jacobsen
,
P. Krogsgaard‐Larsen
,
D. R. Curtis
Journal of Neurochemistry
1985
Corpus ID: 5393298
The relationship between structure, in vivo activity, and in vitro activity of some analogues of the γ‐aminobutyric acid (GABA…
Expand
Highly Cited
1982
Highly Cited
1982
Differences between GABA receptor binding to membranes from cerebellum during postnatal development and from cultured cerebellar granule cells.
E. Meier
,
A. Schousboe
Developmental Neuroscience
1982
Corpus ID: 21001946
GABA receptor binding sites were determined in membranes from cerebella of 7-, 15- and 60-day-old rats and cerebellar granule…
Expand
Review
1979
Review
1979
Partial agonists for brain GABA/benzodiazepine receptor complex
C. Braestrup
,
M. Nielsen
,
P. Krogsgaard‐Larsen
,
E. Falch
Nature
1979
Corpus ID: 6483705
BENZODIAZEPINE receptors in the brain1 are activated by γ-aminobutyric acid (GABA) and by the GABA agonist muscimol in vitro2…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE